New Study Finds Aspirin Treatment Ineffective for Chronic Rhinosinusitis with Nasal Polyps
A recent clinical trial reveals that aspirin therapy offers no significant benefit for patients with chronic rhinosinusitis with nasal polyps, especially those hypersensitive to NSAIDs, emphasizing the need for alternative treatment approaches.
Recent research from the University of Eastern Finland, in collaboration with the University of Helsinki and HUS Inflammation Center, has revealed that aspirin therapy does not significantly improve symptoms or quality of life for patients suffering from chronic rhinosinusitis with nasal polyps (CRSwNP), particularly in those hypersensitive to non-steroidal anti-inflammatory drugs (NSAIDs). The study was published in the journal Allergy and involves a comprehensive clinical trial involving 26 patients with NSAID-exacerbated respiratory disease (N-ERD), asthma, and severe CRSwNP.
The trial involved administering aspirin desensitization to these patients, then randomly assigning them to receive either daily aspirin or a placebo over an 11-month period. The results showed no notable difference in symptom severity, lung function, or the number of corticosteroid courses needed during flare-ups between the two groups. While some indications suggested that aspirin therapy might slightly reduce nasal polyps and improve nasal symptom-related quality of life, these effects were not statistically significant.
Furthermore, adverse effects were common, occurring in 56% of patients taking aspirin and 30% of those on placebo. Side effects ranged from worsening respiratory symptoms, increased bleeding tendencies, to abdominal discomfort. About 18% of patients in the aspirin group discontinued treatment due to side effects. The study concludes that aspirin therapy, despite being affordable, does not offer a reliable benefit for most patients with CRSwNP and hypersensitivity to NSAIDs, and identifying individuals who might benefit remains challenging.
This research highlights the importance of evidence-based treatments and suggests that current biologic medications, although effective, are often expensive. The findings aim to guide clinicians in making informed decisions about managing CRSwNP associated with NSAID hypersensitivity.
Source: https://medicalxpress.com/news/2025-09-aspirin-therapy-ineffective-chronic-rhinosinusitis.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
AI Engineering of T Cell Receptors Boosts Precision Cancer Immunotherapy
AI-powered design of T cell receptor substitutes enhances targeting accuracy in cancer immunotherapy, paving the way for personalized, effective treatments.
New Online Screening Tool Assesses Risk of Energy Deficiency in Young Active Women
A new online questionnaire developed by Penn State helps identify the risk of energy deficiency in young, active women, promoting early detection and health management. The FED-Q offers a fast, safe screening method to support women’s health and athletic performance.
New Insights into How Fruit Fly Brain Creates Spatial Maps Supporting Navigation
Discover how recent research uncovers the neural mechanisms in fruit flies that create spatial maps, providing new understanding of navigation and spatial learning through neural plasticity.
Salmonella Outbreak Leads to Major Egg Recall Across Nine States
A salmonella outbreak has led to a recall of over 1.7 million eggs across nine states, causing illness in dozens. Learn how to identify and respond to contaminated eggs.